Patents by Inventor Yuriy Kalyan

Yuriy Kalyan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthesis of Beta-Arrestin Effectors
    Publication number: 20180016301
    Abstract: Embodiments disclosed herein provide compounds and methods for preparing Beta-Arrestin Effectors.
    Type: Application
    Filed: February 17, 2017
    Publication date: January 18, 2018
    Inventors: Nhut K. Diep, Yuriy Kalyan, Graham Lawton, Matthew Ronsheim, Shao Hong Zhou, Saibaba Racha
  • Synthesis of beta-arrestin effectors
    Patent number: 9611293
    Abstract: Embodiments disclosed herein provide compounds and methods for preparing Beta-Arrestin Effectors.
    Type: Grant
    Filed: May 19, 2015
    Date of Patent: April 4, 2017
    Assignee: Trevena, Inc.
    Inventors: Nhut K. Diep, Yuriy Kalyan, Graham Lawton, Matthew Ronsheim, Shao Hong Zhou, Saibaba Racha
  • Synthesis of Beta-Arrestin Effectors
    Publication number: 20150329593
    Abstract: Embodiments disclosed herein provide compounds and methods for preparing Beta-Arrestin Effectors.
    Type: Application
    Filed: May 19, 2015
    Publication date: November 19, 2015
    Inventors: Nhut K. Diep, Yuriy Kalyan, Graham Lawton, Matthew Ronsheim, Shao Hong Zhou, Saibaba Racha
  • METHODS FOR PREPARING DPP-IV INHIBITOR COMPOUNDS
    Publication number: 20100240611
    Abstract: Methods for preparing an inhibitor of dipeptidyl peptidase IV, as well as formulations of such inhibitors of dipeptidyl peptidase IV that have a high degree of stability including under warm, humid storage conditions.
    Type: Application
    Filed: March 16, 2010
    Publication date: September 23, 2010
    Inventors: Matthew Ronsheim, Nhut Diep, Yuriy Kalyan, Graham Lawton, Peng Wang, Michael Ouellette
  • Reducing carbohydrate derivatives of adamantane amines, and synthesis and methods of use thereof
    Publication number: 20060211650
    Abstract: The present invention relates to reducing carbohydrate derivatives of adamantane amines of Formula A or pharmaceutically acceptable salts, solvates or derivatives thereof, wherein R1, R2, R3, and R4 are together or separately H, F, methyl or lower alkyl, alkenyl, or alkynyl groups, and Z is derived from a mono-, di-, oligo-, or poly-saccharide that originally had an aldehyde carbonyl group. The present invention also relates to processes for the preparation of such adamantane amine derivatives, and uses of such derivatives. The compounds of the present invention are useful in the treatment of infections caused by Gram positive or Gram negative bacteria.
    Type: Application
    Filed: December 14, 2005
    Publication date: September 21, 2006
    Applicant: Forest Laboratories, Inc.
    Inventors: Sebastian Assenza, Nanzhu Shen, Salvatore Iacono, Yuriy Kalyan, Peter Viski, Matthew Ronsheim